Global Tamiflu (Oseltamivir Phosphate) Market Size, Share, Forecast Report, 2020-2027

The global Tamiflu (Oseltamivir Phosphate) market garnered revenue around USD 1.2 Billion in 2019 and projected to reach USD 941 Million in 2027, with at a compound annual growth rate (CAGR) 4.2% throughout the estimate period from 2020 to 2027. Influenza, also known as flu, is an infectious disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type a, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. Tamiflu (Oseltamivir Phosphate) is an effective antiviral agent used for the treatment of influenza symptoms. The market for Tamiflu (Oseltamivir Phosphate) is dominated by North America in 2019, which is expected to be replaced by Asia Pacific by the end of 2027 in terms of revenue.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Tamiflu (Oseltamivir Phosphate) market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Tamiflu (Oseltamivir Phosphate) market growth.

The global Tamiflu (Oseltamivir Phosphate) market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

the global market include F.Hoffmann-La Roche Ltd., NATCO Pharma Limited, Tea Pharmaceutical Industries Ltd., LUPIN Limited, Amneal Pharmaceuticals LLC, Zydus Cadila, Sun Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, Mylan N.V., 

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Tamiflu (Oseltamivir Phosphate) Market: Segmentation

  • Tamiflu (Oseltamivir Phosphate) Market, by Drug Type
    • Branded
    • Generic
  • Tamiflu (Oseltamivir Phosphate) Market, by Dosage Form
    • Capsule
    • Suspension
  • Tamiflu (Oseltamivir Phosphate) Market, by Indication
    • Influenza A
    • Influenza B
    • Others
  • Tamiflu (Oseltamivir Phosphate) Market, by Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Others

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Rest of EU
  • Asia Pacific
    • China
    • India
    • Japan
    • Southeast Asia
    • Rest of APAC
  • Central & South America
    • Brazil
    • Argentina
    • Rest of Central & South America
  • Middle East and Africa
    • UAE
    • Saudi Arabia
    • Rest of MEA